Fig. 6 | Laboratory Investigation

Fig. 6

From: Nanovesicle-mediated delivery of anticancer agents effectively induced cell death and regressed intrahepatic tumors in athymic mice

Fig. 6

Effect of doxorubicin and dox-MNV on HCC cells. HepG2, Hep3B, and PLC/PRF/5 HCC cells were treated with regular doxorubicin and dox-MNV at final concentrations of 500 and 750 nM for 72 h and assayed for cell viability. There was significant difference in the rate of cell death between regular doxorubicin and dox-MNV at 500 nM in the case of HepG2 and Hep3B cells (a). The difference was not significant at 750 nM (b). The data are mean ± SD (n = 8)

Back to article page